The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Hip FracturesClinical PharmacistsRehabilitation Outcome
Interventions
OTHER

Pharmaceutical intervention

Pharmaceutical intervention will include a complete medication review by a clinical pharmacist with the following process: medication reconciliation, medication indication and dosage check, medication effectiveness and appropriateness assessment, drug-drug or drug-disease interactions check, medication duplications check, length and cost of treatment evaluation. The pharmacist will use the following tools: Medication appropriateness index (MAI), ACB (Anticholinergic cognitive burden) score and the using the assessment of underutilization (AOU) index.

OTHER

Rehabilitation

A multidisciplinary team provided medical, nursing, physical, occupational, and social work interventions. Rehabilitation care include: (a) individual physical therapy (PT), 2 to 3 times a week; (b) 30 to 40 min of PT in an adapted fitness room, aerobic training on a treadmill with and without partial weight support and stationary bicycles, 2 to 3 times a week ; (c) 30 to 40 min of virtual reality training by performing challenging functional tasks, 2 times a week and (d) 30 to 45 min of individual occupational therapy (OT), cognitive evaluation and stimulation, safety education, and learning to use assistive devices, 3 times a week.

Trial Locations (1)

Unknown

Beit Rivka geriatric rehabilitation center, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT04360746 - The Influence of Clinical Pharmacist on the Quality of Drug Prescribing and Rehabilitation Outcomes in Post-acute Hip Fractured Patients | Biotech Hunter | Biotech Hunter